The essential malaria drug artemisinin acts like a “ticking time bomb” in parasite cells --…
eabramovichSeptember 24, 2020
A unique, protective cell envelope contributes to the broad drug resistance of the nosocomial pathogen Acinetobacter…
eabramovichSeptember 23, 2020
A new study led by Boston Medical Center researchers indicates a well-known biomarker that serves…
eabramovichSeptember 23, 2020
The Center for Integrated Management of Antimicrobial Resistance, a collaborative effort supported by Tufts University…
eabramovichSeptember 23, 2020
Vincent Breton-Provencher, a postdoc in the lab of Picower Institute investigator Mriganka Sur, is among a…
eabramovichSeptember 22, 2020
Developing the best possible cancer therapies is the driving force of Dana-Farber Cancer Institute, but…
eabramovichSeptember 22, 2020
To achieve the goal of eradicating malaria set by the World Health Organization (WHO)’s Global Malaria…
eabramovichSeptember 22, 2020
Excited to be the first patient in a novel clinical trial, Jon Woods is hoping…
eabramovichSeptember 21, 2020
In the last decade, cancer immunotherapies have demonstrated improved clinical outcomes in patients with a…
eabramovichSeptember 21, 2020
